The Oesophageal Manometry Probe Market is growing alongside the increasing use of specialized diagnostic technologies for gastrointestinal health. WiseGuyReports reports a market size of approximately USD 300 million in 2024 and 2025, with the value expected to reach USD 500 million by 2035 at a 5.9% CAGR over the 2026–2035 forecast period.

The market is segmented into solid-state probes, water-perfused probes, and high-resolution manometry probes, each serving different clinical requirements. High-resolution systems are particularly important because they can provide detailed pressure measurements along the esophagus. Advances in probe technology and data visualization are helping clinicians obtain more comprehensive information during gastrointestinal evaluations.

From an application perspective, the market covers gastroesophageal reflux disease, achalasia, dysphagia, and esophageal motility disorders. The growing burden of gastrointestinal conditions is increasing the need for accurate diagnostic testing. GERD represents a major area of demand, while achalasia and other motility disorders require specialized measurements that support clinical diagnosis and treatment planning.

Hospitals account for an important share of demand, supported by their specialized diagnostic departments and access to gastroenterology services. Ambulatory surgical centers and diagnostic laboratories are also expanding the potential user base. North America remains the leading region, Europe maintains a developed healthcare market, and Asia Pacific is showing strong growth potential as healthcare expenditure and awareness of esophageal disorders increase.

Future market opportunities are likely to come from connected devices, AI-assisted analysis, minimally invasive diagnostic workflows, and single-use probe technology. Manufacturers that focus on accuracy, patient comfort, infection control, and efficient data interpretation can address changing clinical requirements. Continued investment in gastrointestinal diagnostics and improved access to specialized healthcare are expected to support the market's development through 2035.